<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">Researchers from the National Health Research Institutes in Taiwan combined old and new methods in order to hunt for existing drugs that could turn out to be of help in the fight against SARS-CoV-2: while Ke et al. trained artificial intelligence to skim through compound databases [
 <xref rid="bib23" ref-type="bibr">23</xref>], Yang et al. experimentally screened 252 molecules for potential inhibition of the feline infectious peritonitis (FIP) coronavirus and the human coronavirus OC43 (HCoV-OC43) in a cell culture model [
 <xref rid="bib13" ref-type="bibr">13</xref>]. This led to the identification of 15 compounds displaying activity against both viruses, and provided further feedback and training material to the abovementioned machine learning platform, thus demonstrating the fertile synergy of 
 <italic>in silico</italic> methods and benchwork.
</p>
